A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation

Delphi G. M. Coppens; Sofieke de Wilde; Henk J. Guchelaar; Marie L. De Bruin; Hubert G. M. Leufkens; Pauline Meij; Jarno Hoekman

A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation

Delphi G. M. Coppens, Sofieke de Wilde, Henk J. Guchelaar, Marie L. De Bruin, Hubert G. M. Leufkens, Pauline Meij, Jarno Hoekman

Copenhagen Centre for Regulatory Science

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	Pharmacoepidemiology and Drug Safety
Vol/bind	27
Udgave nummer	S2
Sider (fra-til)	517-517
ISSN	1053-8569
Status	Udgivet - 2018

Adgang til dokumentet

https://onlinelibrary.wiley.com/toc/10991557/2018/27/S2

Biblioteksadgang?

Tjek tilgængelighed hos det Kgl. Bibliotek

Citationsformater

Coppens, D. G. M., de Wilde, S., Guchelaar, H. J., De Bruin, M. L., Leufkens, H. G. M., Meij, P., & Hoekman, J. (2018). A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation. Pharmacoepidemiology and Drug Safety, 27(S2), 517-517. https://onlinelibrary.wiley.com/toc/10991557/2018/27/S2

A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation. / Coppens, Delphi G. M.; de Wilde, Sofieke; Guchelaar, Henk J. et al.
I: Pharmacoepidemiology and Drug Safety, Bind 27, Nr. S2, 2018, s. 517-517.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › peer review

Coppens, DGM, de Wilde, S, Guchelaar, HJ, De Bruin, ML, Leufkens, HGM, Meij, P & Hoekman, J 2018, 'A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation', Pharmacoepidemiology and Drug Safety, bind 27, nr. S2, s. 517-517. <https://onlinelibrary.wiley.com/toc/10991557/2018/27/S2>

@article{b9a55e48130640cfa26799bd2dfd7fe6,

title = "A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan: A regulatory decision-making evaluation",

author = "Coppens, {Delphi G. M.} and {de Wilde}, Sofieke and Guchelaar, {Henk J.} and {De Bruin}, {Marie L.} and Leufkens, {Hubert G. M.} and Pauline Meij and Jarno Hoekman",

year = "2018",

language = "English",

volume = "27",

pages = "517--517",

journal = "Pharmacoepidemiology and Drug Safety",

issn = "1053-8569",

publisher = "JohnWiley & Sons Ltd",

number = "S2",

}

TY - ABST

T1 - A decade of marketing approval of gene and cell based therapies in the United States, European Union, and Japan

T2 - A regulatory decision-making evaluation

AU - Coppens, Delphi G. M.

AU - de Wilde, Sofieke

AU - Guchelaar, Henk J.

AU - De Bruin, Marie L.

AU - Leufkens, Hubert G. M.

AU - Meij, Pauline

AU - Hoekman, Jarno

PY - 2018

Y1 - 2018

M3 - Conference abstract in journal

SN - 1053-8569

VL - 27

SP - 517

EP - 517

JO - Pharmacoepidemiology and Drug Safety

JF - Pharmacoepidemiology and Drug Safety

IS - S2

ER -